Literature DB >> 28687102

The Clinical Evaluation of Angioedema.

Parwinder Gill1, Stephen D Betschel2.   

Abstract

The clinical evaluation of angioedema is reliant on obtaining a thorough patient and family history with an assessment of risk factors and presenting symptoms unique to each subtype. It is important to distinguish between angioedema with and without urticaria as a primary step in the evaluation; thereafter, laboratory parameters and investigations allow for subsequent stratification. There is a significant disease burden associated with angioedema and thus it is essential for health care practitioners to establish a prompt and accurate diagnosis, and a comprehensive care plan that addresses the patient's physical and mental well-being alike. Crown
Copyright © 2017. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angioedema; Bradykinin; Hereditary angioedema; Histamine

Mesh:

Substances:

Year:  2017        PMID: 28687102     DOI: 10.1016/j.iac.2017.04.007

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  4 in total

1.  The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.

Authors:  Marcus Maurer; Markus Magerl; Stephen Betschel; Werner Aberer; Ignacio J Ansotegui; Emel Aygören-Pürsün; Aleena Banerji; Noémi-Anna Bara; Isabelle Boccon-Gibod; Konrad Bork; Laurence Bouillet; Henrik Balle Boysen; Nicholas Brodszki; Paula J Busse; Anette Bygum; Teresa Caballero; Mauro Cancian; Anthony J Castaldo; Danny M Cohn; Dorottya Csuka; Henriette Farkas; Mark Gompels; Richard Gower; Anete S Grumach; Guillermo Guidos-Fogelbach; Michihiro Hide; Hye-Ryun Kang; Allen P Kaplan; Constance H Katelaris; Sorena Kiani-Alikhan; Wei-Te Lei; Richard F Lockey; Hilary Longhurst; William Lumry; Andrew MacGinnitie; Alejandro Malbran; Inmaculada Martinez Saguer; Juan José Matta Campos; Alexander Nast; Dinh Nguyen; Sandra A Nieto-Martinez; Ruby Pawankar; Jonathan Peter; Grzegorz Porebski; Nieves Prior; Avner Reshef; Marc Riedl; Bruce Ritchie; Farrukh Rafique Sheikh; William B Smith; Peter J Spaeth; Marcin Stobiecki; Elias Toubi; Lilian Agnes Varga; Karsten Weller; Andrea Zanichelli; Yuxiang Zhi; Bruce Zuraw; Timothy Craig
Journal:  World Allergy Organ J       Date:  2022-04-07       Impact factor: 5.516

2.  ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients.

Authors:  David S Weisman; Nelly Arnouk; M Bilal Asghar; M Raheel Qureshi; Anagha Kumar; Sameer Desale; Lyn Camire; Stephen Pineda
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-02-10

3.  Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study.

Authors:  Anete S Grumach; Marina T Henriques; Maine L D Bardou; Daniele A Pontarolli; Jaco Botha; Mariangela Correa
Journal:  An Bras Dermatol       Date:  2022-05-30       Impact factor: 2.113

4.  [Postoperative angioedema induced by angiotensin-converting enzyme inhibitor: case report].

Authors:  Flora Margarida Barra Bisinotto; Beatrice Cavalcanti Seabra; Fernando B Prata Lóes; Laura Bisinotto Martins; Luciano Alves Matias da Silveira
Journal:  Braz J Anesthesiol       Date:  2019-09-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.